Clinical comparison of the nitrosoureas
- PMID: 1100221
- DOI: 10.1002/1097-0142(197510)36:4<1258::aid-cncr2820360411>3.0.co;2-6
Clinical comparison of the nitrosoureas
Abstract
The nitrosourea group of antitumor agents was developed by the Division of Cancer Treatment of the National Cancer Institute. Three nitrosoureas (BCNU, CCNU, MeCCNU) have undergone extensive clinical trials, and two of them (BCNU, CCNU) will soon become commercially available. This paper briefly considers the preclinical development of the nitrosoureas and provides an overview and comparison of the extensive clinical data. Information is given regarding any clinical differences. We discuss general conclusions drawn from the nitrosourea development.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources